GXXIX | VIGIX | GXXIX / VIGIX | |
Total Expense Ratio | 0.96 | 0.04 | 2,400% |
Annual Report Gross Expense Ratio | 0.99 | 0.04 | 2,475% |
Fund Existence | 25 years | 27 years | - |
Gain YTD | -6.535 | -9.620 | 68% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 1000000 | 5000000 | 20% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 315M | 283B | 0% |
Annual Yield % from dividends | 0.00 | 0.52 | - |
Returns for 1 year | -5.49 | 7.73 | -71% |
Returns for 3 years | -2.39 | 28.59 | -8% |
Returns for 5 years | 17.34 | 143.37 | 12% |
Returns for 10 years | -3.53 | 246.35 | -1% |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
JFNNX | 67.71 | 0.80 | +1.20% |
Janus Henderson Global Life Sciences N | |||
CSGIX | 9.59 | 0.05 | +0.52% |
Calamos International Small Cap Gr I | |||
MNNCX | 32.55 | N/A | N/A |
Victory Munder Multi-Cap C | |||
BIECX | 22.52 | N/A | N/A |
Brandes International Equity C | |||
FEUCX | 18.28 | N/A | N/A |
Fidelity Advisor Glbl Capital Apprec C |